More Bystanders Are Using Naloxone to Save Folks From Overdose
By Dennis Thompson HealthDay Reporter
MONDAY, Oct. 14, 2024 -- More bystanders are stepping in to administer naloxone to people who’ve overdosed on opioids, a new study shows.
Nearly 25,000 OD patients received naloxone from an untrained bystander before paramedics arrived, according to emergency medical services records from June 2020 to June 2022.
“Our findings revealed that people receiving naloxone from laypersons increased by 43.5%, proving that public health efforts are working,” said researcher Chris Gage, a doctoral student at the Ohio State University College of Public Health.
However, researchers also noted that more work needs to be done to improve awareness of naloxone, based on the EMS data.
Only about 3% of all OD patients who received naloxone got it from non-medical bystanders, results show.
“In a perfect world, this should be closer to a 100%, highlighting a need to improve naloxone education, enhance access and investigate and remove obstacles to its use,” Gage said in a news release.
Naloxone rapidly reverses an overdose by blocking opioid receptors in the body.
“Naloxone is a lifesaving medication that can reverse opioid overdose effects when given immediately,” said senior researcher Dr. Ashish Panchal, a clinical professor of emergency medicine at Ohio State University. “Similar to CPR, stepping up to help before emergency crews arrive can be the difference between life and death.”
During the past decade, there’s been an ongoing campaign to improve access to and awareness of naloxone, researchers said.
Last year, the U.S. Food and Drug Administration approved over-the-counter sales of naloxone, and the drug is frequently prescribed whenever someone is prescribed narcotics for medical purposes like pain relief.
In addition, 46 states and the District of Columbia have passed laws that provide legal immunity for Good Samaritans who step in to help someone having an opioid overdose, researchers noted.
Future research will look into groups that make naloxone available to bystanders, and how to make sure the drug is available for patients in need, the team said.
The new study was published in the journal JAMA Network Open.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-15 00:00
Read more
- FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome
- Taxi Drivers' Brains May Leave Them Less Vulnerable to Alzheimer's
- FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis
- Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
- Satsuma Pharmaceuticals and SNBL Receive FDA Acceptance of NDA Resubmission of STS101 for the Acute Treatment of Migraine With or Without Aura
- Two Common Antiseizure Medications Do Not Harm Child Neurodevelopment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions